Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CHMP Recommends Approvals of RINVOQ for the Active Psoriatic Arthritis, Ankylosing Spondylitis

americanpharmaceuticalreviewDecember 31, 2020

Tag: CHMP , Rinvoq , AbbVie , psoriatic arthritis

PharmaSources Customer Service